• レポートコード:MRC2303A128 • 出版社/出版日:Persistence Market Research / 2022年12月30日 • レポート形態:英文、PDF、336ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥735,000 (USD4,900) | ▷ お問い合わせ |
Site Licence | ¥1,140,000 (USD7,600) | ▷ お問い合わせ |
Enterprisewide | ¥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社発行の当調査レポートでは、世界の医療シミュレーション市場の現状について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、価格分析、需要分析・予測、市場背景、市場構造分析、競争分析、仮定、調査手法などの構成でまとめております。セグメント分析では、製品&サービス別(モデル/シミュレーター、ソフトウェア、サービス)、技術別(低忠実度医療シミュレーション、中忠実度医療シミュレーション、高忠実度医療シミュレーション)、エンドユーザー別(学術機関、病院&診療所、軍事組織、その他)、地域別(北米、中南米、ヨーロッパ、東アジア、南アジア太平洋、中東/アフリカ)の情報が含まれています。なお、当市場の主要企業には、CAE Inc.、Mentice、Gaumard Scientific、Limbs & Things LTD、3D Systems、Intelligent Ultrasound、Kyoto Kagaku、Operative Experience, Inc.、Synaptive Medical、3B Scientific、Laerdal Medical、VRmagic Holding AG、VirtaMed AG、Invous Limited、SynBone AGなどが含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・価格分析 ・需要分析・予測 ・市場背景 ・世界の医療シミュレーション市場規模:製品&サービス別 - モデル/シミュレーターの市場規模 - ソフトウェアの市場規模 - サービスの市場規模 ・世界の医療シミュレーション市場規模:技術別 - 低忠実度医療シミュレーションの市場規模 - 中忠実度医療シミュレーションの市場規模 - 高忠実度医療シミュレーションの市場規模 ・世界の医療シミュレーション市場規模:エンドユーザー別 - 学術機関における市場規模 - 病院&診療所における市場規模 - 軍事組織における市場規模 - その他エンドユーザーにおける市場規模 ・世界の医療シミュレーション市場規模:地域別 - 北米の医療シミュレーション市場規模 - 中南米の医療シミュレーション市場規模 - ヨーロッパの医療シミュレーション市場規模 - 東アジアの医療シミュレーション市場規模 - 南アジア太平洋の医療シミュレーション市場規模 - 中東/アフリカの医療シミュレーション市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Medical Simulation Market – Report Scope
Persistence Market Research recently published a new report on the medical simulation market. The report provides a detailed valuation on key market dynamics, such as the drivers, trends, opportunities, and restraints, along with detailed information about the market structure. This research report presents exclusive facts and figures about how the medical simulation market will grow over the forecast period of 2023 to 2033.
Key indicators of market background, such as value chain analysis and supply chain, compounded annual growth rate (CAGR), and year-on-year (Y-o-Y) growth of the market are explained in Persistence Market Research’s study in a comprehensive manner. This information can help readers understand the quantitative development projections of the medical simulation market over the forecast period.
The study is relevant for stakeholders in the medical simulation market, as well as manufacturers, distributors, suppliers, and investors, as it can help them understand applicable strategies to grow in the market. Stakeholders, investors, industry experts, researchers, and journalists, as well as business researchers in market can leverage the information and statistics presented in this research report.
The report includes facts & figures related to the micro as well as macro-economic factors that are impacting the growth of the medical simulation market. The study also offers actionable insights based on future trends in the market. Furthermore, domestic players and new entrants in the market can also use the information presented in this report to make business decisions and gain momentum in the market.
Key Segments of Market
Persistence Market Research’s study on the medical simulation market is divided into four significant segments: product & services, technology, end user and region. This report offers comprehensive data and information about the important market dynamics and growth parameters related to these categories.
Product & Services
Models/Simulators
Software
Services
Technology
Low-fidelity Medical Simulation
Medium-fidelity Medical Simulation
High-fidelity Medical Simulation
End User
Medical Simulation for Academic Institutions
Medical Simulation for Hospitals & Clinics
Medical Simulation for Military Organizations
Others
Region
North America
Latin America
Europe
East Asia
South Asia Pacific
Middle East and Africa
Key Questions Answered in Report
Which region is anticipated to hold a prominent market share over the forecast period?
What will be the key driving factors propelling the demand medical simulation across the world during the forecast period?
How current trends will impact the medical simulation market?
Who are significant market participants in the market?
What are the crucial strategies of prominent players in the medical simulation market to upscale their positions in this landscape?
Research Methodology
In Persistence Market Research’s research report, exclusive research methodology is utilized to conduct comprehensive research on the development of the medical simulation market, and reach conclusions on the future growth factors of the market. In this research methodology, secondary and primary research is utilized by analysts to ensure the precision and reliability of the conclusions.
Secondary resources are referred by analysts during the evaluation of the medical simulation market study, which comprises of facts and figures from white papers, trade journals, and external and internal databases. Analysts have thoroughly interviewed several industry experts, such as sales supervisors, sales operation managers, product portfolio managers, senior managers, market intelligence managers, marketing/product managers, engineering managers, and production managers to provide insightful information.
Comprehensive information acquired from primary and secondary resources is validated by companies operating in the medical simulation market, to make Persistence Market Research’s projections on the growth prospects of the market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Solution Innovation / Development Trends
4. Pricing Analysis
4.1. Pricing Analysis, By Products
4.1.1. Hardware Pricing Analysis
4.1.2. Software Pricing Analysis
4.2. Average Pricing Analysis Benchmark
5. Global Medical Simulation Market Demand (in Value in US$ Mn) Analysis 2018-2022 and Forecast, 2023-2033
5.1. Historical Market Value (US$ Mn) Analysis, 2018-2022
5.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.2. Forecast Factors – Relevance & Impact
6.3. Value Chain
6.4. COVID-19 Crisis – Impact Assessment
6.4.1. Current Statistics
6.4.2. Short-Mid-Long Term Outlook
6.4.3. Likely Rebound
6.5. Market Dynamics
6.5.1. Drivers
6.5.2. Restraints
6.5.3. Opportunities
7. Global Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033, by Product & Services
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product & Services, 2018 – 2022
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product & Services, 2023 – 2033
7.3.1. Models/Simulators
7.3.1.1. Healthcare Simulation Anatomical Models
7.3.1.2. Patient Simulators
7.3.1.3. Task Trainers
7.3.1.4. Interventional/Surgical Simulators
7.3.1.4.1. Laparoscopic Surgical Simulators
7.3.1.4.2. Gynecology Surgical Simulators
7.3.1.4.3. Cardiac Surgical Simulators
7.3.1.4.4. Arthroscopic Surgical Simulators
7.3.1.4.5. Others
7.3.2. Software
7.3.2.1. Web-based Simulation
7.3.2.2. Healthcare Simulation Software
7.3.3. Services
7.3.3.1. Simulation Training Services
7.3.3.2. Educational Societies
7.3.3.3. Custom Consulting Services
7.4. Market Attractiveness Analysis By Product & Services
8. Global Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033, by Technology
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Technology, 2018 – 2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2023 – 2033
8.3.1. Low-fidelity Medical Simulation
8.3.2. Medium-fidelity Medical Simulation
8.3.3. High-fidelity Medical Simulation
8.4. Market Attractiveness Analysis By Technology
9. Global Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033, by End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2018 – 2022
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023 – 2033
9.3.1. Medical Simulation for Academic Institutions
9.3.2. Medical Simulation for Hospitals & Clinics
9.3.3. Medical Simulation for Military Organizations
9.3.4. Others
9.4. Market Attractiveness Analysis By End User
10. Global Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033, by Region
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2018 – 2022
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2023 – 2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia Pacific
10.3.6. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 – 2022
11.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 – 2033
11.3.1. By Product & Services
11.3.2. By Technology
11.3.3. By End User
11.3.4. By Country
11.3.4.1. U.S.
11.3.4.2. Canada
11.4. Market Attractiveness Analysis
11.4.1. By Product & Services
11.4.2. By Technology
11.4.3. By End User
11.4.4. By Country
11.5. Market Trends
11.6. Key Market Participants – Intensity Mapping
12. Latin America Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 – 2022
12.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 – 2033
12.3.1. By Product & Services
12.3.2. By Technology
12.3.3. By End User
12.3.4. By Country
12.3.4.1. Brazil
12.3.4.2. Mexico
12.3.4.3. Rest of Latin America
12.4. Market Attractiveness Analysis
12.4.1. By Product & Services
12.4.2. By Technology
12.4.3. By End User
12.4.4. By Country
13. Europe Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 – 2022
13.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 – 2033
13.3.1. By Product & Services
13.3.2. By Technology
13.3.3. By End User
13.3.4. By Country
13.3.4.1. Germany
13.3.4.2. Italy
13.3.4.3. France
13.3.4.4. U.K.
13.3.4.5. Spain
13.3.4.6. BENELUX
13.3.4.7. Russia
13.3.4.8. Rest of Europe
13.4. Market Attractiveness Analysis
13.4.1. By Product & Services
13.4.2. By Technology
13.4.3. By End User
13.4.4. By Country
14. South Asia & Pacific Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 – 2022
14.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 – 2033
14.3.1. By Product & Services
14.3.2. By Technology
14.3.3. By End User
14.3.4. By Country
14.3.4.1. India
14.3.4.2. Indonesia
14.3.4.3. Malaysia
14.3.4.4. Singapore
14.3.4.5. Australia & New Zealand
14.3.4.6. Rest of South Asia and Pacific
14.4. Market Attractiveness Analysis
14.4.1. By Product & Services
14.4.2. By Technology
14.4.3. By End User
14.4.4. By Country
15. East Asia Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 – 2022
15.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 – 2033
15.3.1. By Product & Services
15.3.2. By Technology
15.3.3. By End User
15.3.4. By Country
15.3.4.1. China
15.3.4.2. Japan
15.3.4.3. South Korea
15.4. Market Attractiveness Analysis
15.4.1. By Product & Services
15.4.2. By Technology
15.4.3. By End User
15.4.4. By Country
16. Middle East and Africa Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 – 2022
16.3. Current and Future Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 – 2033
16.3.1. By Product & Services
16.3.2. By Technology
16.3.3. By End User
16.3.4. By Country
16.3.4.1. GCC Countries
16.3.4.2. Turkey
16.3.4.3. South Africa
16.3.4.4. Rest of Middle East and Africa
16.4. Market Attractiveness Analysis
16.4.1. By Product & Services
16.4.2. By Technology
16.4.3. By End User
16.4.4. By Country
17. Key Countries Analysis- Medical Simulation Market
17.1. U.S. Medical Simulation Market Analysis
17.1.1. By Product & Services
17.1.2. By Technology
17.1.3. By End User
17.2. Canada Medical Simulation Market Analysis
17.2.1. By Product & Services
17.2.2. By Technology
17.2.3. By End User
17.3. Mexico Medical Simulation Market Analysis
17.3.1. By Product & Services
17.3.2. By Technology
17.3.3. By End User
17.4. Brazil Medical Simulation Market Analysis
17.4.1. By Product & Services
17.4.2. By Technology
17.4.3. By End User
17.5. Germany Medical Simulation Market Analysis
17.5.1. By Product & Services
17.5.2. By Technology
17.5.3. By End User
17.6. Italy Medical Simulation Market Analysis
17.6.1. By Product & Services
17.6.2. By Technology
17.6.3. By End User
17.7. France Medical Simulation Market Analysis
17.7.1. By Product & Services
17.7.2. By Technology
17.7.3. By End User
17.8. U.K. Medical Simulation Market Analysis
17.8.1. By Product & Services
17.8.2. By Technology
17.8.3. By End User
17.9. Spain Medical Simulation Market Analysis
17.9.1. By Product & Services
17.9.2. By Technology
17.9.3. By End User
17.10. BENELUX Medical Simulation Market Analysis
17.10.1. By Product & Services
17.10.2. By Technology
17.10.3. By End User
17.11. Russia Medical Simulation Market Analysis
17.11.1. By Product & Services
17.11.2. By Technology
17.11.3. By End User
17.12. Rest of Europe Medical Simulation Market Analysis
17.12.1. By Product & Services
17.12.2. By Technology
17.12.3. By End User
17.13. China Medical Simulation Market Analysis
17.13.1. By Product & Services
17.13.2. By Technology
17.13.3. By End User
17.14. Japan Medical Simulation Market Analysis
17.14.1. By Product & Services
17.14.2. By Technology
17.14.3. By End User
17.15. South Korea Medical Simulation Market Analysis
17.15.1. By Product & Services
17.15.2. By Technology
17.15.3. By End User
17.16. India Medical Simulation Market Analysis
17.16.1. By Product & Services
17.16.2. By Technology
17.16.3. By End User
17.17. Malaysia Medical Simulation Market Analysis
17.17.1. By Product & Services
17.17.2. By Technology
17.17.3. By End User
17.18. Indonesia Medical Simulation Market Analysis
17.18.1. By Product & Services
17.18.2. By Technology
17.18.3. By End User
17.19. Singapore Medical Simulation Market Analysis
17.19.1. By Product & Services
17.19.2. By Technology
17.19.3. By End User
17.20. Australia and New Zealand Medical Simulation Market Analysis
17.20.1. By Product & Services
17.20.2. By Technology
17.20.3. By End User
17.21. GCC Countries Medical Simulation Market Analysis
17.21.1. By Product & Services
17.21.2. By Technology
17.21.3. By End User
17.22. Turkey Medical Simulation Market Analysis
17.22.1. By Product & Services
17.22.2. By Technology
17.22.3. By End User
17.23. South Africa Medical Simulation Market Analysis
17.23.1. By Product & Services
17.23.2. By Technology
17.23.3. By End User
17.24. Rest of Middle East and Africa Medical Simulation Market Analysis
17.24.1. By Product & Services
17.24.2. By Technology
17.24.3. By End User
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. CAE Inc.
19.3.1.1. Business Overview
19.3.1.2. Solution Portfolio
19.3.1.3. Profitability by Market Segments (Business Segments/Region)
19.3.1.4. Key Strategy & Developments
19.3.2. Mentice
19.3.2.1. Business Overview
19.3.2.2. Solution Portfolio
19.3.2.3. Profitability by Market Segments (Business Segments/Region)
19.3.2.4. Key Strategy & Developments
19.3.3. Gaumard Scientific
19.3.3.1. Business Overview
19.3.3.2. Solution Portfolio
19.3.3.3. Profitability by Market Segments (Business Segments/Region)
19.3.3.4. Key Strategy & Developments
19.3.4. Limbs & Things LTD
19.3.4.1. Business Overview
19.3.4.2. Solution Portfolio
19.3.4.3. Profitability by Market Segments (Business Segments/Region)
19.3.4.4. Key Strategy & Developments
19.3.5. 3D Systems
19.3.5.1. Business Overview
19.3.5.2. Solution Portfolio
19.3.5.3. Profitability by Market Segments (Business Segments/Region)
19.3.5.4. Key Strategy & Developments
19.3.6. Intelligent Ultrasound
19.3.6.1. Business Overview
19.3.6.2. Solution Portfolio
19.3.6.3. Profitability by Market Segments (Business Segments/Region)
19.3.6.4. Key Strategy & Developments
19.3.7. Kyoto Kagaku
19.3.7.1. Business Overview
19.3.7.2. Solution Portfolio
19.3.7.3. Profitability by Market Segments (Business Segments/Region)
19.3.7.4. Key Strategy & Developments
19.3.8. Operative Experience, Inc.
19.3.8.1. Business Overview
19.3.8.2. Solution Portfolio
19.3.8.3. Profitability by Market Segments (Business Segments/Region)
19.3.8.4. Key Strategy & Developments
19.3.9. Synaptive Medical
19.3.9.1. Business Overview
19.3.9.2. Solution Portfolio
19.3.9.3. Profitability by Market Segments (Business Segments/Region)
19.3.9.4. Key Strategy & Developments
19.3.10. 3B Scientific
19.3.10.1. Business Overview
19.3.10.2. Solution Portfolio
19.3.10.3. Profitability by Market Segments (Business Segments/Region)
19.3.10.4. Key Strategy & Developments
19.3.11. Laerdal Medical
19.3.11.1. Business Overview
19.3.11.2. Solution Portfolio
19.3.11.3. Profitability by Market Segments (Business Segments/Region)
19.3.11.4. Key Strategy & Developments
19.3.12. VRmagic Holding AG
19.3.12.1. Business Overview
19.3.12.2. Solution Portfolio
19.3.12.3. Profitability by Market Segments (Business Segments/Region)
19.3.12.4. Key Strategy & Developments
19.3.13. VirtaMed AG
19.3.13.1. Business Overview
19.3.13.2. Solution Portfolio
19.3.13.3. Profitability by Market Segments (Business Segments/Region)
19.3.13.4. Key Strategy & Developments
19.3.14. Invous Limited
19.3.14.1. Business Overview
19.3.14.2. Solution Portfolio
19.3.14.3. Profitability by Market Segments (Business Segments/Region)
19.3.14.4. Key Strategy & Developments
19.3.15. SynBone AG
19.3.15.1. Business Overview
19.3.15.2. Solution Portfolio
19.3.15.3. Profitability by Market Segments (Business Segments/Region)
19.3.15.4. Key Strategy & Developments
20. Assumptions and Acronyms Used
21. Research Methodology